Formerly known as TGA BioServices, Absorption Systems Boston (“ASB”) is a GLP/GMP facility offering support from early drug discovery through Phase IV clinical trials. With a core competency in assay development and validation, the ASB team routinely creates robust methodologies for compound screening, product characterization, PK/PD analysis, biomarkers such as cytokines/chemokines, potency, stability, and immunogenic response (ADA, NAb) using the following techniques:
Quantitative Western Blot
Enzyme Activity Assays
Fluorescent and Luminescent Assays
Cell Based Assays
Complementing the comprehensive array of bioanalytical and bioassay services, the ASB facility includes a research-use only vivarium suitable for housing mice, rats, hamsters, and guinea pigs. While providing flexibility in the execution of customized designs for a Sponsor, the ASB in-life team routinely performs PK and immunogenicity studies.
This facility is FDA/EMA Inspected, USDA Registered and Inspected, AAALAC Accredited, DEA Licensed, OLAW Assured.